 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
The Food and Drug Administration has approved updated labeling for Abilify, a drug made jointly by Bristol-Myers Squibb and Japans Otsuka Pharmaceuticals
|
|
|
|
|
|
|
|
|
The Japan Patent Office has licensed GeneCards by Xennex. The company also announced that it has selected Bioscene Informatics as its exclusive partner for the distribution of GeneCards in Japan
|
|
|
|
|
|
|
| | | 
BioSpectrum Japan is uniquely positioned as a specialized information platform for Japanese medical technology articles. It brings to you comprehensive coverage and useful Japan medical news in the areas of pharmaceuticals industry in Japan, Japanese medical technology, Japan medical devices and Biotech.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
|
|
Japan patent office licenses Xennex's GeneCards
|
|
| The Japan Patent Office has licensed GeneCards by Xennex. The company also announced that it has selected Bioscene Informatics as its exclusive partner for the distribution of GeneCards in Japan |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
|
|
We bridge manufacturer and wholesaler:RIJ
|
|
| Research & Innovation Japan, located in Shiroi, North East of Tokyo, is a one-year-old consulting company that helps foreign companies penetrate into the Japanese market |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
|
|
Sosei restructures Board
|
|
| Sosei has changed its Board of Directors. The new non-executive directors include Dr Declan Doogan, Mr Eiji Katayama, Dr Alan Lewis and Mr Isao Muramatsu |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Faust Pharma signs research agreement with Takeda
|
|
| Faust Pharmaceuticals, a clinical-stage product company specializing in the discovery and development of drugs for diseases of the nervous system from France has entered into a research agreement with Takeda Pharmaceutical Company. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
|
|
CV, Astellas get FDA approval for Lexiscan injection
|
|
| CV Therapeutics and the US arm of Japanese firm Astellas Pharma have received approval from the US FDA for Lexiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
AnGes launches Naglazyme in Japan
|
|
| Japanese biopharmaceutical company AnGes has launched Naglazyme (galsulfase) for patients with the genetic disease mucopolysaccharidosis VI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
